Best of Molecular Therapy Award

About the Award

This award, supported by Phil and Nancy Reilly, highlights the contribution of a lead author under the age of 40 to the Molecular Therapy family of journals.

Nomination Criteria

The award recipient will be:

  • An ASGCT member in good standing

  • The first author on an original research article published in the Molecular Therapy family of journals in the calendar year

  • Under the age of 40 at the time the article is published

All lead authors meeting these criteria are eligible. The best article will be identified by the ASGCT Publications Committee and approved by the Board of Directors. The Committee may consider factors including the novelty of the underlying science and the impact the article is projected to have on the development of gene and cell therapy.

The recipient of the award will be announced in advance of the Annual Meeting and receive a cash award of $2,500.

Nominations for the 2022 Annual Meeting will be accepted beginning Fall 2021.


26th Annual Meeting

May 16-20 | Los Angeles, CA

This site uses cookies to offer you a better user experience and to analyze site traffic. By continuing to use this website, you accept our use of cookies.